Bio-Rad Laboratories, Inc. (BIO.B) balance sheet
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Bio-Rad Laboratories, Inc. balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 51.9%
- Operating margin
- 2.1%
- Net margin
- 8.6%
- Return on equity, FY2025
- 10.8%
Financial strength
- Current ratio
- 3.14
- Debt to equity
- 0.11
- Debt to assets
- 7.8%
- Cash to current liabilities
- 53.8%
Valuation
- P/E ratio
- 46.2
- Price to sales
- 3.93
- Price to book
- 1.42
- Dividend yield
- –